HKG:0719 Revenue

In the year 2024, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.47B CNY with 4.51% growth. Shandong Xinhua Pharmaceutical Company had revenue of 1.73B in the quarter ending December 31, 2024, with 8.04% growth.

Revenue

8.47B CNY

Revenue Growth

+4.51%

P/S Ratio

0.44

Revenue / Employee

1.19M CNY

Employees

7,104

Market Cap

9.22B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.47B	365.47M	4.51%
Dec 31, 2023	8.10B	597.86M	7.97%
Jan 1, 2023	7.50B	942.91M	14.37%
Dec 31, 2021	6.56B	554.49M	9.23%
Dec 31, 2020	6.01B	399.57M	7.13%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeiGene	29.60B
Hansoh Pharmaceutical Group Company	13.05B
JD Health International	61.89B
WuXi Biologics	19.87B
Innovent Biologics	10.03B
Akeso	2.26B
Alibaba Health Information Technology	31.39B
Sichuan Kelun-Biotech Biopharmaceutical	2.06B

Revenue Rankings